Our Blogs
Harnessing Light for
Holistic Wellness
Last updated: 2026-03-27
Reading duration: 16 minutes
Breast pain keeps coming back, your current options feel limited, and you want something that actually works without adding side effects.
Red light therapy uses wavelengths in the 630–850 nm range to reduce tissue inflammation, support cellular repair, and ease discomfort in the breast area. While research specific to mastalgia is still emerging, evidence from wound healing, breastfeeding support, and post-surgical recovery points to real potential — especially when combined with standard care.
Red light therapy breast pad used for breast pain relief in a wellness setting
In this guide, we break down exactly what breast pain is, how red light therapy targets the mechanisms behind it, which types of breast pain respond best, and what treatment parameters actually matter. We also cover safety, compare RLT to traditional options, and share what we at REDDOT LED have learned from working with clinics and home-use customers.
Breast pain — clinically called mastalgia — is one of the most common breast complaints. It accounts for roughly 41% of referrals to specialist breast clinics, yet breast pain alone is almost never a sign of cancer. That gap between how common it is and how little attention it receives leaves many women frustrated.
The pain itself ranges from a dull monthly ache to sharp, constant discomfort that interferes with sleep, exercise, and daily routines. And here is the part that surprises most people: traditional treatments often fall short. Topical NSAIDs help, but not always. Hormonal therapies carry real side effects. Evening primrose oil, once widely recommended, has shown no proven benefit over placebo.
That is the gap where red light therapy enters the conversation.
Understanding the type of breast pain is the first step toward knowing whether RLT might help.
Cyclic mastalgia affects about two-thirds of women with breast pain. It follows the menstrual cycle — worse in the week before your period, then easing off. The pain is typically bilateral, diffuse, and driven by fluctuations in estrogen, progesterone, and prolactin.
Noncyclic mastalgia accounts for the other third. It does not follow a menstrual pattern. Instead, it tends to be unilateral, localized, and tied to something structural: a cyst, prior surgery, mastitis, trauma, or large breast size. This type is more common after age 40.
Extramammary pain is not true breast pain — it originates from the chest wall, ribs, or pectoral muscles but is felt in the breast. Costochondritis is a frequent culprit.
Types of breast pain: Periodic breast pain, non-periodic breast pain, extramammary pain
| Feature | Cyclic | Noncyclic | Extramammary |
|---|---|---|---|
| Pattern | Follows menstrual cycle | No cycle link; constant or erratic | Variable; often positional |
| Location | Both breasts, upper-outer | One breast, localized | Chest wall, ribs, referred |
| Common age | 20–50 (premenopausal) | 40+; may persist post-menopause | Any age |
| Main drivers | Hormonal fluctuations | Cysts, surgery, mastitis, trauma | Costochondritis, muscle strain |
| RLT relevance | Limited (hormonal root) | Moderate to high (inflammation, repair) | Moderate (musculoskeletal relief) |
Red light therapy (RLT), also called photobiomodulation (PBM) or low-level light therapy (LLLT), delivers specific wavelengths of red and near-infrared light to stimulate biological processes inside cells. It is non-invasive, drug-free, and does not use ultraviolet radiation.
The technology has been around longer than most people think. NASA first explored it in the 1990s for plant growth in space and wound healing for astronauts. Dermatologists have used it for years in photodynamic therapy for precancerous skin lesions. Since the National Library of Medicine added "photobiomodulation" as an official MeSH term in 2015, published research has grown rapidly.
Devices range from large clinical panels and treatment beds down to handheld wands, wraps, and contoured pads designed for specific body areas — including breast-shaped pads built for targeted treatment.
The therapeutic effects of RLT come down to what happens inside your cells when they absorb specific wavelengths of light. Three mechanisms are most relevant to breast pain.
The primary target is an enzyme called cytochrome c oxidase (CCO), sitting inside the mitochondrial electron transport chain. When red or near-infrared photons reach CCO, they knock off inhibitory nitric oxide molecules, restoring normal electron flow. The result: more ATP — the cell's energy currency.
More ATP means cells repair faster, respond to inflammation more effectively, and regenerate damaged tissue with greater efficiency. This is not theoretical. Multiple studies have confirmed increased ATP production, improved mitochondrial membrane potential, and enhanced cellular metabolism after PBM exposure.
Inflammation drives many forms of breast pain — from the tissue edema of cyclic mastalgia to the active swelling of mastitis. RLT modulates inflammatory cytokines, dialing down pro-inflammatory signals like TNF-α and IL-6 while supporting resolution pathways.
Here is an interesting detail: PBM activates the NF-κB pathway through reactive oxygen species, which sounds like it should increase inflammation. But the downstream gene expression actually promotes anti-inflammatory outcomes. Block NF-κB, and you lose the anti-inflammatory benefit. The biology is more nuanced than "light reduces swelling."
Red light promotes vasodilation — widening blood vessels to increase local blood flow. More blood means more oxygen, more nutrients reaching damaged tissue, and faster removal of metabolic waste. Stanford Medicine researchers have pointed to vasodilation as the likely mechanism behind many of RLT's documented tissue benefits.
On top of that, RLT stimulates fibroblast activity and collagen production. For breast pain tied to surgical scars, capsular contracture, or breastfeeding-related nipple damage, this tissue-remodeling effect matters.
How red light therapy works on breast tissue — mechanism of action diagram
Not every kind of breast pain is a good fit for RLT. The therapy's strengths — reducing inflammation, accelerating tissue repair, relieving localized pain — match some conditions far better than others.
Mastitis, breast abscesses (post-treatment), and post-radiation inflammation align well with what PBM does best. If the pain is driven by active tissue inflammation, RLT has a logical role.
Women recovering from lumpectomy, mastectomy, reconstruction, or augmentation often deal with persistent pain and scarring. A study presented at the American Academy of Cosmetic Surgery found that LED therapy using infrared, red, and blue light significantly reduced the need for revision surgery in women developing capsular contracture after breast augmentation.
We have seen growing interest from plastic surgery clinics looking for non-invasive post-op support tools. This is one area where the evidence and the clinical demand line up well.
Nipple pain, fissures, and engorgement affect up to 80% of breastfeeding mothers, and nearly 20% stop nursing earlier than planned because of persistent discomfort. A meta-analysis of seven studies found that diode laser light at various wavelengths reduced pain from nipple trauma — fissures, cracks, abrasions. Additional small studies showed that laser therapy applied to the breasts increased serum prolactin and milk production.
One controlled study reported that mothers receiving photobiomodulation had lower pain scores and greater infant weight gain compared to controls.
Do not overlook this. For postpartum care providers and lactation consultants, RLT is worth knowing about.
Cyclic mastalgia is fundamentally hormonal. RLT does not change hormone levels. But the localized anti-inflammatory and circulation effects may provide comfort during the luteal phase when tissue edema peaks. Think of it as symptom management, not a fix for the underlying hormonal cycle.
LLLT has been used in supportive care for breast cancer patients — managing lymphedema, radiation dermatitis, and post-surgical pain. But the direct effects of light on tumor cells remain controversial. Some in vitro research shows anti-proliferative effects of 660 nm light on breast cancer cell lines, but this is not enough to guide clinical practice.
The rule is simple: do not use RLT near active tumors without explicit approval from the treating oncology team.
No large-scale randomized controlled trial has studied RLT specifically for general mastalgia. That is an important gap to acknowledge. However, the evidence from related areas is relevant and growing.
Pain reduction: A review of 11 studies on RLT for various pain types found predominantly positive results. Studies on temporomandibular dysfunction, rheumatoid arthritis, and tendinopathy all showed pain relief — particularly in conditions involving tissue inflammation.
Wound healing: Research dates back to the 1960s. A Stanford-cited blepharoplasty study found that red light-treated scars healed in half the time of untreated controls, though differences equalized by six weeks. Early-phase healing appears to benefit most.
Breastfeeding support: The LactMed database reports that laser therapy is acceptable during breastfeeding. A meta-analysis of seven studies confirmed effectiveness for nipple trauma pain. Small randomized studies demonstrated increased serum prolactin and milk production with laser therapy applied to the breasts.
Capsular contracture: LED therapy with infrared, red, and blue light significantly reduced the need for surgical intervention in women developing capsular contracture after breast augmentation, per research presented at the American Academy of Cosmetic Surgery.
What is missing: Breast-pain-specific RCTs, standardized treatment protocols, and long-term outcome data. The field needs more rigorous, mastalgia-focused research before RLT can be considered a standard treatment.
These parameters come from the broader photobiomodulation literature and clinical practice. They are starting points — not prescriptions. Always consult a healthcare provider before beginning any new therapy.
| Parameter | Recommended range | Notes |
|---|---|---|
| Wavelength | 630–660 nm (red) + 810–850 nm (NIR) | Combination covers superficial and deeper tissue |
| Irradiance | 10–100 mW/cm² | Clinical: 30–100 mW/cm²; home: 10–50 mW/cm² |
| Dose (fluence) | 4–30 J/cm² per session | Lower (4–10) for surface pain; higher (15–30) for deeper tissue |
| Session time | 5–20 minutes per area | Higher irradiance = shorter session for same dose |
| Frequency | 3–5 sessions per week | Daily for acute issues; 2–3x/week for maintenance |
| Treatment cycle | 4–12 weeks initial course | Reassess at 4–6 weeks. Benefits may take 2–4 weeks to appear |
| Distance | Contact or 0–6 inches | Contact pads deliver most efficiently; panels at 6–12 inches |
Start low. Track your symptoms. Adjust based on what you notice over 2–4 weeks. Consistency matters more than intensity.
Using a red light therapy breast pad at home for pain management
Understanding where RLT fits relative to conventional options helps you make a practical decision rather than an emotional one.
| Treatment | Best for | Invasiveness | Side effects | Evidence level | Typical cost |
|---|---|---|---|---|---|
| Red light therapy | Inflammatory pain, post-surgical, breastfeeding | Non-invasive | Minimal (mild warmth, rare redness) | Emerging | $50–$500 device; $50–$150/clinic session |
| Topical NSAIDs | Cyclic and noncyclic pain | Non-invasive (topical) | Possible skin irritation | Strong (RCT-supported) | $5–$20/month |
| Hormonal therapy | Severe cyclic pain unresponsive to other Tx | Systemic medication | Significant (thrombosis, mood, weight) | Strong but limited by side effects | $20–$100+/month |
| OTC pain meds | Acute flare-ups | Oral medication | GI irritation, liver risk with overuse | Strong for short-term | $5–$15/month |
| Supportive bra fitting | All types (foundational) | Non-invasive | None | Moderate | $30–$80 one-time |
The takeaway: RLT is not competing with topical NSAIDs or bra fitting — it complements them. Where it fills a gap is in providing a drug-free, at-home option for ongoing support between clinical visits.
RLT works best when it is part of a plan, not the entire plan.
With topical NSAIDs: Apply RLT before or after using diclofenac gel. The improved blood flow from RLT may enhance drug penetration, and the anti-inflammatory effects may be additive.
After surgery: Introduce RLT after initial wound closure to support tissue healing, reduce scar formation, and manage residual pain. Always coordinate with the surgical team.
During breastfeeding: Short sessions between feeds may accelerate healing of nipple fissures. The LactMed database considers laser therapy acceptable during lactation. But — and this matters — work with a lactation consultant to fix the underlying latch issues causing the damage.
With lifestyle changes: A well-fitting bra, reduced caffeine, stress management, and a healthy diet address the root environment of breast discomfort. RLT adds targeted relief on top of that foundation.
Red light therapy has a strong safety profile when used as directed. But breast tissue requires specific caution.
Myth: Red light therapy can cure breast pain.
Reality: RLT is a complementary tool. It may reduce inflammation and promote tissue repair, but the underlying cause of breast pain needs proper diagnosis and treatment.
Myth: All red light devices are the same.
They are not. A $30 wand from an online marketplace and a medical-grade breast pad with verified wavelengths and irradiance specifications are fundamentally different products.
Myth: If some light is good, more is better.
PBM follows a biphasic dose response. Too little energy and you get no effect. Too much and you can actually inhibit the cellular response. The sweet spot matters. Follow the parameters, track your results, and adjust.
Best practice: Keep a simple symptom log. Note your pain level before and after each session, the time and duration of treatment, and any changes over weeks. This gives you — and your healthcare provider — real data to work with.
Best practice for clinics: If you are integrating RLT into your practice, start with one well-specified device and a clear protocol for your most common use case. Do not try to launch five applications at once. We have seen many clinics succeed by starting with one panel and one protocol, then expanding based on patient feedback.
Q: How often should I use red light therapy for breast pain?
A: For acute discomfort, daily sessions of 10–15 minutes for the first 2–3 weeks is a reasonable starting point. For ongoing maintenance, 2–3 sessions per week may be sufficient. Consistency matters more than individual session length.
Q: Can I use red light therapy while breastfeeding?
A: Yes. The LactMed database considers laser and light therapy acceptable during breastfeeding. Some studies suggest it may even support milk production. Work with a lactation consultant to address the root cause of nipple pain alongside RLT.
Q: Does red light therapy cause or increase the risk of breast cancer?
A: There is no evidence that RLT causes breast cancer. Red and near-infrared light do not carry the mutagenic properties of UV radiation. However, do not use RLT near known or suspected tumors without oncologist approval.
Q: What is the difference between a home device and a clinical treatment?
A: Clinical devices deliver higher irradiance and more precise wavelengths under professional supervision. Home devices are less powerful but offer convenience and cost savings over time. For breast pain, a medical-grade contoured pad with documented specifications offers the best balance for home use.
Q: Should I stop my current medication if I start RLT?
A: No. RLT is complementary. Never stop prescribed medications or treatments without discussing with your healthcare provider.
Red light therapy is not a cure for breast pain. It is a non-invasive, drug-free tool with a growing evidence base that may help reduce inflammation, support tissue repair, and ease discomfort — especially for inflammatory breast conditions, post-surgical recovery, and breastfeeding-related pain.
The science behind photobiomodulation is well-established. The gap is in mastalgia-specific clinical trials. As those studies arrive, the picture will sharpen. For now, RLT earns its place as a complementary option for women looking beyond conventional treatments.
If you are a clinic, rehabilitation center, or brand exploring red light therapy for women's health applications, we at REDDOT LED provide medical-grade devices designed for targeted treatment — including breast-contoured PBM pads, full-body panels, and custom OEM/ODM solutions with certification support.
REDDOT LED red light therapy device lineup for breast pain and women's health